Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 16, 2014
Technology Networks
 
Register | Sign in
Home Page > Videos > SYNAPT G2-S MS
  Videos

Return

SYNAPT G2-S MS
Waters Corporation

To access the highest levels of information content from your most analytically challenging samples, or utilize analytical tools to make scientific discoveries not possible by any other means, look no further than SYNAPT® G2-S MS. SYNAPT G2-S MS combines revolutionary high performance StepWave™ ion optics, Quantitative Tof (QuanTof™) and Triwave® technologies with unique systems design and support, as well as a unique upgrade path to High Definition MS™ capability:

‘All in’ performance — Achieve the most comprehensive and confident untargeted identification and quantification of compounds with UPLC®/MS/MS, at the lowest levels in complex samples

Upgrade to HDMS™ and access new discoveries — Every scientist can recover unparalleled information content and make new discoveries not possible any other way, by leveraging high-efficiency ion mobility separations with high resolution exact mass tandem MS

Maximum versatility — Serve the broadest range of applications with the most extensive range of targeted data acquisition, chromatographic inlet and ion source capabilities

Instant efficiency — Realize maximum system usability and efficiency across your organisation through Waters design philosophy of Engineered Simplicity™

Accelerated success — Maximize your success with complete application system solutions backed by a superior applications and technical support network

For over 50 years, Waters Corporation has created business advantages for laboratory-dependent organizations. By delivering practical and sustainable scientific innovation, Waters enables significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide. For more information, visit www.waters.com.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
Mass Spectrometry in Your Hand
Electrospray arrays can dramatically downsize systems and costs for onsite chemical analysis and many other applications.
Study Aims to Develop Breath Test for COPD
A new clinical iniative, lead by NYU Langone Medical Center, aims to determine a breath test’s effectiveness to identify volatile organic compounds (VOCs) in human breath that are biomarkers of chronic obstructive pulmonary disease (COPD).
Comparison of Caffeinated and Decaffeinated Coffee - Implications for Alzheimer's Disease
Researchers from the National University of Singapore successfully demonstrated the viability of GC-TOF-MS as an analytical platform for metabolomics analysis of coffee samples.
Repressing the Repressors May Drive Tissue-Specific Cancers
Stowers scientists establish Drosophila and mammalian models to study mutations found in pediatric brain tumors.
Embalming Study ‘Rewrites’ Key Chapter in Egyptian History
New evidence to suggest that the origins of mummification started in ancient Egypt 1,500 years earlier than previously thought.
Identification of Psoriatic Arthritis Mediators in Synovial Fluid
This study represents the most comprehensive proteomic analysis of psoriatic arthritis synovial fluid, to date.
Mass Spec-Based Metabolomics Workflows to Evaluate Plant Immunity
This article reviews metabolomics studies used to evaluate plant immunity with an emphasis on mass spectrometry in its many forms.
Using LC-MS to Analyse Sulfonamides in Food Grade Honey
Sulfonamides are one of a number of groups of chemicals whose presence in honey is limited by international regulations.
Reimagining UHPLC
To learn more about the new Vanquish UHPLC system from Thermo Fisher Scientific we spoke to Wulff Niedner, Director of HPLC Product Marketing.
Mass Spec Predicts Improved Response to Anti-HER2 Therapy in Breast Cancer
Immunohistochemistry is the standard technique for detecting HER2 protein expression, it does not provide absolute quantification of this receptor and is prone to false-positives.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv